市場調査レポート

商品コード

腎臓結石治療の世界市場 2024-2028

Global kidney stones therapeutic market 2024-2028

出版日: 2024年05月22日
発行: TechNavio
ページ情報: 英文 168 Pages
納期: 即納可能

カスタマイズ可能

価格

PDF (Single User License)

USD 2,500 358,925円

レポートPDFをご購入者の1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 4,000 574,280円

レポートPDFを同一組織内のすべての方にて共有ご使用頂けるライセンスです。ご利用人数に制限はありません。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は制限なく何回でも可能ではありますが、印刷物のご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=143.57円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

腎臓結石治療市場は2023-2028年に5億3,780万米ドル、予測期間中のCAGRは4.96％で成長すると予測されています。

当レポートでは、腎臓結石治療市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。同市場は、軟性デジタル尿管鏡の普及拡大、世界人口における尿路結石症の罹患率の上昇、腎結石症の有病率の増加によって牽引されています。

市場範囲
基準年	2024
終了年	2028
予測期間	2024-2028
成長モメンタム	加速
前年比2024年	4.64%
CAGR	4.96%
増分額	5億3,780万米ドル

本調査では、今後数年間の腎臓結石治療市場成長を牽引する主要因の1つとして、腎臓結石治療技術の進歩を挙げています。また、高齢者人口の増加、社会的認知度の向上、医師教育、臨床トレーニングへの取り組みが、市場の大きな需要につながるとしています。

地域別セグメンテーション
地域別比較
北米：市場規模と予測 2023-2028
欧州：市場規模と予測 2023-2028
アジア：市場規模と予測 2023-2028
世界のその他の地域：市場規模と予測 2023-2028
米国：市場規模と予測 2023-2028
中国：市場規模と予測 2023-2028
ドイツ：市場規模と予測 2023-2028
カナダ：市場規模と予測 2023-2028
英国：市場規模と予測 2023-2028
市場機会：地域別

第10章促進要因・課題・機会・抑制要因

市場促進要因
市場の課題
促進要因と課題の影響
市場の機会・抑制要因

第11章競合情勢

概要
競合情勢
混乱の状況
業界のリスク

第12章競合分析

企業プロファイル
企業の市場ポジショニング
Anvik Biotech
Aristo Pharma GmbH
Bausch Health Companies Inc.
Bayer AG
Cipla Inc.
Dr Reddys Laboratories Ltd.
Emcure Pharmaceuticals Ltd.
GlaxoSmithKline Plc
Intas Pharmaceuticals Ltd.
Macleods Pharmaceuticals Ltd.
Medinova Diagnostic Services Ltd.
Pfizer Inc.
Walter Bushnell
Windlas Biotech Pvt. Ltd.
Worth Medicines Pvt. Ltd.

第13章付録

図表

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits6: Executive Summary - Chart on Market Segmentation by Type
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Company Market Positioning
Exhibits10: Parent Market
Exhibits11: Data Table on - Parent Market
Exhibits12: Market characteristics analysis
Exhibits13: Value Chain Analysis
Exhibits14: Offerings of companies included in the market definition
Exhibits15: Market segments
Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits20: Historic Market Size - Data Table on Global Kidney Stones Therapeutic Market 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Type Segment 2018 - 2022 ($ million)
Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits25: Five forces analysis - Comparison between 2023 and 2028
Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits31: Chart on Market condition - Five forces 2023 and 2028
Exhibits32: Chart on End-user - Market share 2023-2028 (%)
Exhibits33: Data Table on End-user - Market share 2023-2028 (%)
Exhibits34: Chart on Comparison by End-user
Exhibits35: Data Table on Comparison by End-user
Exhibits36: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibits37: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibits38: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibits39: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibits40: Chart on Specialty clinics - Market size and forecast 2023-2028 ($ million)
Exhibits41: Data Table on Specialty clinics - Market size and forecast 2023-2028 ($ million)
Exhibits42: Chart on Specialty clinics - Year-over-year growth 2023-2028 (%)
Exhibits43: Data Table on Specialty clinics - Year-over-year growth 2023-2028 (%)
Exhibits44: Chart on Ambulatory surgical centers - Market size and forecast 2023-2028 ($ million)
Exhibits45: Data Table on Ambulatory surgical centers - Market size and forecast 2023-2028 ($ million)
Exhibits46: Chart on Ambulatory surgical centers - Year-over-year growth 2023-2028 (%)
Exhibits47: Data Table on Ambulatory surgical centers - Year-over-year growth 2023-2028 (%)
Exhibits48: Market opportunity by End-user ($ million)
Exhibits49: Data Table on Market opportunity by End-user ($ million)
Exhibits50: Chart on Type - Market share 2023-2028 (%)
Exhibits51: Data Table on Type - Market share 2023-2028 (%)
Exhibits52: Chart on Comparison by Type
Exhibits53: Data Table on Comparison by Type
Exhibits54: Chart on Lithotripsy - Market size and forecast 2023-2028 ($ million)
Exhibits55: Data Table on Lithotripsy - Market size and forecast 2023-2028 ($ million)
Exhibits56: Chart on Lithotripsy - Year-over-year growth 2023-2028 (%)
Exhibits57: Data Table on Lithotripsy - Year-over-year growth 2023-2028 (%)
Exhibits58: Chart on Ureteroscopy - Market size and forecast 2023-2028 ($ million)
Exhibits59: Data Table on Ureteroscopy - Market size and forecast 2023-2028 ($ million)
Exhibits60: Chart on Ureteroscopy - Year-over-year growth 2023-2028 (%)
Exhibits61: Data Table on Ureteroscopy - Year-over-year growth 2023-2028 (%)
Exhibits62: Chart on Percutaneous nephrolithonomy (PCNL) - Market size and forecast 2023-2028 ($ million)
Exhibits63: Data Table on Percutaneous nephrolithonomy (PCNL) - Market size and forecast 2023-2028 ($ million)
Exhibits64: Chart on Percutaneous nephrolithonomy (PCNL) - Year-over-year growth 2023-2028 (%)
Exhibits65: Data Table on Percutaneous nephrolithonomy (PCNL) - Year-over-year growth 2023-2028 (%)
Exhibits66: Market opportunity by Type ($ million)
Exhibits67: Data Table on Market opportunity by Type ($ million)
Exhibits68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits69: Chart on Market share by geography 2023-2028 (%)
Exhibits70: Data Table on Market share by geography 2023-2028 (%)
Exhibits71: Chart on Geographic comparison
Exhibits72: Data Table on Geographic comparison
Exhibits73: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits74: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits75: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits76: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits77: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits78: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits79: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits80: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits81: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits82: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits83: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits85: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits86: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits87: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits88: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits89: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits90: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits91: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits92: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits93: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits94: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits95: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits96: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits97: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits98: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits99: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits100: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits101: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits102: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits103: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits104: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits105: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits106: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits107: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits108: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits109: Market opportunity by geography ($ million)
Exhibits110: Data Tables on Market opportunity by geography ($ million)
Exhibits111: Impact of drivers and challenges in 2023 and 2028
Exhibits112: Overview on criticality of inputs and factors of differentiation
Exhibits113: Overview on factors of disruption
Exhibits114: Impact of key risks on business
Exhibits115: Companies covered
Exhibits116: Matrix on companies position and classification
Exhibits117: Anvik Biotech - Overview
Exhibits118: Anvik Biotech - Product / Service
Exhibits119: Anvik Biotech - Key offerings
Exhibits120: Aristo Pharma GmbH - Overview
Exhibits121: Aristo Pharma GmbH - Product / Service
Exhibits122: Aristo Pharma GmbH - Key offerings
Exhibits123: Bausch Health Companies Inc. - Overview
Exhibits124: Bausch Health Companies Inc. - Business segments
Exhibits125: Bausch Health Companies Inc. - Key news
Exhibits126: Bausch Health Companies Inc. - Key offerings
Exhibits127: Bausch Health Companies Inc. - Segment focus
Exhibits128: Bayer AG - Overview
Exhibits129: Bayer AG - Business segments
Exhibits130: Bayer AG - Key news
Exhibits131: Bayer AG - Key offerings
Exhibits132: Bayer AG - Segment focus
Exhibits133: Cipla Inc. - Overview
Exhibits134: Cipla Inc. - Business segments
Exhibits135: Cipla Inc. - Key news
Exhibits136: Cipla Inc. - Key offerings
Exhibits137: Cipla Inc. - Segment focus
Exhibits138: Dr Reddys Laboratories Ltd. - Overview
Exhibits139: Dr Reddys Laboratories Ltd. - Business segments
Exhibits140: Dr Reddys Laboratories Ltd. - Key news
Exhibits141: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits142: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits143: Emcure Pharmaceuticals Ltd. - Overview
Exhibits144: Emcure Pharmaceuticals Ltd. - Product / Service
Exhibits145: Emcure Pharmaceuticals Ltd. - Key offerings
Exhibits146: GlaxoSmithKline Plc - Overview
Exhibits147: GlaxoSmithKline Plc - Business segments
Exhibits148: GlaxoSmithKline Plc - Key news
Exhibits149: GlaxoSmithKline Plc - Key offerings
Exhibits150: GlaxoSmithKline Plc - Segment focus
Exhibits151: Intas Pharmaceuticals Ltd. - Overview
Exhibits152: Intas Pharmaceuticals Ltd. - Product / Service
Exhibits153: Intas Pharmaceuticals Ltd. - Key offerings
Exhibits154: Macleods Pharmaceuticals Ltd. - Overview
Exhibits155: Macleods Pharmaceuticals Ltd. - Product / Service
Exhibits156: Macleods Pharmaceuticals Ltd. - Key offerings
Exhibits157: Medinova Diagnostic Services Ltd. - Overview
Exhibits158: Medinova Diagnostic Services Ltd. - Product / Service
Exhibits159: Medinova Diagnostic Services Ltd. - Key offerings
Exhibits160: Pfizer Inc. - Overview
Exhibits161: Pfizer Inc. - Product / Service
Exhibits162: Pfizer Inc. - Key news
Exhibits163: Pfizer Inc. - Key offerings
Exhibits164: Walter Bushnell - Overview
Exhibits165: Walter Bushnell - Product / Service
Exhibits166: Walter Bushnell - Key offerings
Exhibits167: Windlas Biotech Pvt. Ltd. - Overview
Exhibits168: Windlas Biotech Pvt. Ltd. - Product / Service
Exhibits169: Windlas Biotech Pvt. Ltd. - Key offerings
Exhibits170: Worth Medicines Pvt. Ltd. - Overview
Exhibits171: Worth Medicines Pvt. Ltd. - Product / Service
Exhibits172: Worth Medicines Pvt. Ltd. - Key offerings
Exhibits173: Inclusions checklist
Exhibits174: Exclusions checklist
Exhibits175: Currency conversion rates for US$
Exhibits176: Research methodology
Exhibits177: Information sources
Exhibits178: Data validation
Exhibits179: Validation techniques employed for market sizing
Exhibits180: Data synthesis
Exhibits181: 360 degree market analysis
Exhibits182: List of abbreviations

Product Code: IRTNTR71823

The kidney stones therapeutic market is forecasted to grow by USD 537.8 mn during 2023-2028, accelerating at a CAGR of 4.96% during the forecast period. The report on the kidney stones therapeutic market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing popularity of flexible digital ureteroscopes, rising incidence of urolithiasis among the global population, and increasing prevalence of kidney stone disease.

Technavio's kidney stones therapeutic market is segmented as below:

Market Scope
Base Year	2024
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	4.64%
CAGR	4.96%
Incremental Value	$537.8mn

By End-user

Hospitals
Specialty clinics
Ambulatory surgical centers

By Type

Lithotripsy
Ureteroscopy
Percutaneous nephrolithonomy (PCNL)

By Geography

North America
Europe
Asia
Rest of World (ROW)

This study identifies the advances in technologies in kidney stones treatment as one of the prime reasons driving the kidney stones therapeutic market growth during the next few years. Also, rising geriatric population and initiatives to increase public awareness, physician education, and clinical training will lead to sizable demand in the market.

The report on the kidney stones therapeutic market covers the following areas:

Kidney stones therapeutic market sizing
Kidney stones therapeutic market forecast
Kidney stones therapeutic market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading kidney stones therapeutic market vendors that include Anvik Biotech, Aristo Pharma GmbH, Bausch Health Companies Inc., Bayer AG, Biomedix Siomond Pharma, Cipla Inc., Cmg Biotech Pvt. Ltd., Dr Reddys Laboratories Ltd., Emcure Pharmaceuticals Ltd., GlaxoSmithKline Plc, Intas Pharmaceuticals Ltd., Johnson and Johnson Services Inc., Macleods Pharmaceuticals Ltd., Medinova Diagnostic Services Ltd., Mission Pharmacal Co., Nostrum Pharmaceuticals LLC, Pfizer Inc., Walter Bushnell, Windlas Biotech Pvt. Ltd., and Worth Medicines Pvt. Ltd.. Also, the kidney stones therapeutic market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
2.2 Market characteristics
- Market characteristics analysis
2.3 Value chain analysis
- Value Chain Analysis

3 Market Sizing

3.1 Market definition
- Offerings of companies included in the market definition
3.2 Market segment analysis
- Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global Kidney Stones Therapeutic Market 2018 - 2022
- Historic Market Size - Data Table on Global Kidney Stones Therapeutic Market 2018 - 2022 ($ million)
4.2 End-user segment analysis 2018 - 2022
- Historic Market Size - End-user Segment 2018 - 2022 ($ million)
4.3 Type segment analysis 2018 - 2022
- Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by End-user

6.1 Market segments
- Chart on End-user - Market share 2023-2028 (%)
- Data Table on End-user - Market share 2023-2028 (%)
6.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
6.3 Hospitals - Market size and forecast 2023-2028
- Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
- Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
- Chart on Hospitals - Year-over-year growth 2023-2028 (%)
- Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
6.4 Specialty clinics - Market size and forecast 2023-2028
- Chart on Specialty clinics - Market size and forecast 2023-2028 ($ million)
- Data Table on Specialty clinics - Market size and forecast 2023-2028 ($ million)
- Chart on Specialty clinics - Year-over-year growth 2023-2028 (%)
- Data Table on Specialty clinics - Year-over-year growth 2023-2028 (%)
6.5 Ambulatory surgical centers - Market size and forecast 2023-2028
- Chart on Ambulatory surgical centers - Market size and forecast 2023-2028 ($ million)
- Data Table on Ambulatory surgical centers - Market size and forecast 2023-2028 ($ million)
- Chart on Ambulatory surgical centers - Year-over-year growth 2023-2028 (%)
- Data Table on Ambulatory surgical centers - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by End-user
- Market opportunity by End-user ($ million)
- Data Table on Market opportunity by End-user ($ million)

7 Market Segmentation by Type

7.1 Market segments
- Chart on Type - Market share 2023-2028 (%)
- Data Table on Type - Market share 2023-2028 (%)
7.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type
7.3 Lithotripsy - Market size and forecast 2023-2028
- Chart on Lithotripsy - Market size and forecast 2023-2028 ($ million)
- Data Table on Lithotripsy - Market size and forecast 2023-2028 ($ million)
- Chart on Lithotripsy - Year-over-year growth 2023-2028 (%)
- Data Table on Lithotripsy - Year-over-year growth 2023-2028 (%)
7.4 Ureteroscopy - Market size and forecast 2023-2028
- Chart on Ureteroscopy - Market size and forecast 2023-2028 ($ million)
- Data Table on Ureteroscopy - Market size and forecast 2023-2028 ($ million)
- Chart on Ureteroscopy - Year-over-year growth 2023-2028 (%)
- Data Table on Ureteroscopy - Year-over-year growth 2023-2028 (%)
7.5 Percutaneous nephrolithonomy (PCNL) - Market size and forecast 2023-2028
- Chart on Percutaneous nephrolithonomy (PCNL) - Market size and forecast 2023-2028 ($ million)
- Data Table on Percutaneous nephrolithonomy (PCNL) - Market size and forecast 2023-2028 ($ million)
- Chart on Percutaneous nephrolithonomy (PCNL) - Year-over-year growth 2023-2028 (%)
- Data Table on Percutaneous nephrolithonomy (PCNL) - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by Type
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)

8 Customer Landscape

8.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Chart on Market share by geography 2023-2028 (%)
- Data Table on Market share by geography 2023-2028 (%)
9.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 China - Market size and forecast 2023-2028
- Chart on China - Market size and forecast 2023-2028 ($ million)
- Data Table on China - Market size and forecast 2023-2028 ($ million)
- Chart on China - Year-over-year growth 2023-2028 (%)
- Data Table on China - Year-over-year growth 2023-2028 (%)
9.9 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.10 Canada - Market size and forecast 2023-2028
- Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Chart on Canada - Year-over-year growth 2023-2028 (%)
- Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.11 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ million)
- Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Opportunity/Restraints

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints

11 Competitive Landscape

11.1 Overview
11.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
- Overview on factors of disruption
11.4 Industry risks
- Impact of key risks on business

12 Competitive Analysis

12.1 Companies profiled
- Companies covered
12.2 Market positioning of companies
- Matrix on companies position and classification
12.3 Anvik Biotech
- Anvik Biotech - Overview
- Anvik Biotech - Product / Service
- Anvik Biotech - Key offerings
12.4 Aristo Pharma GmbH
- Aristo Pharma GmbH - Overview
- Aristo Pharma GmbH - Product / Service
- Aristo Pharma GmbH - Key offerings
12.5 Bausch Health Companies Inc.
- Bausch Health Companies Inc. - Overview
- Bausch Health Companies Inc. - Business segments
- Bausch Health Companies Inc. - Key news
- Bausch Health Companies Inc. - Key offerings
- Bausch Health Companies Inc. - Segment focus
12.6 Bayer AG
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key news
- Bayer AG - Key offerings
- Bayer AG - Segment focus
12.7 Cipla Inc.
- Cipla Inc. - Overview
- Cipla Inc. - Business segments
- Cipla Inc. - Key news
- Cipla Inc. - Key offerings
- Cipla Inc. - Segment focus
12.8 Dr Reddys Laboratories Ltd.
- Dr Reddys Laboratories Ltd. - Overview
- Dr Reddys Laboratories Ltd. - Business segments
- Dr Reddys Laboratories Ltd. - Key news
- Dr Reddys Laboratories Ltd. - Key offerings
- Dr Reddys Laboratories Ltd. - Segment focus
12.9 Emcure Pharmaceuticals Ltd.
- Emcure Pharmaceuticals Ltd. - Overview
- Emcure Pharmaceuticals Ltd. - Product / Service
- Emcure Pharmaceuticals Ltd. - Key offerings
12.10 GlaxoSmithKline Plc
- GlaxoSmithKline Plc - Overview
- GlaxoSmithKline Plc - Business segments
- GlaxoSmithKline Plc - Key news
- GlaxoSmithKline Plc - Key offerings
- GlaxoSmithKline Plc - Segment focus
12.11 Intas Pharmaceuticals Ltd.
- Intas Pharmaceuticals Ltd. - Overview
- Intas Pharmaceuticals Ltd. - Product / Service
- Intas Pharmaceuticals Ltd. - Key offerings
12.12 Macleods Pharmaceuticals Ltd.
- Macleods Pharmaceuticals Ltd. - Overview
- Macleods Pharmaceuticals Ltd. - Product / Service
- Macleods Pharmaceuticals Ltd. - Key offerings
12.13 Medinova Diagnostic Services Ltd.
- Medinova Diagnostic Services Ltd. - Overview
- Medinova Diagnostic Services Ltd. - Product / Service
- Medinova Diagnostic Services Ltd. - Key offerings
12.14 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
12.15 Walter Bushnell
- Walter Bushnell - Overview
- Walter Bushnell - Product / Service
- Walter Bushnell - Key offerings
12.16 Windlas Biotech Pvt. Ltd.
- Windlas Biotech Pvt. Ltd. - Overview
- Windlas Biotech Pvt. Ltd. - Product / Service
- Windlas Biotech Pvt. Ltd. - Key offerings
12.17 Worth Medicines Pvt. Ltd.
- Worth Medicines Pvt. Ltd. - Overview
- Worth Medicines Pvt. Ltd. - Product / Service
- Worth Medicines Pvt. Ltd. - Key offerings

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
13.3 Currency conversion rates for US$
- Currency conversion rates for US$
13.4 Research methodology
- Research methodology
13.5 Data procurement
- Information sources
13.6 Data validation
- Data validation
13.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
13.8 Data synthesis
- Data synthesis
- 360 degree market analysis
- 360 degree market analysis
13.10 List of abbreviations
- List of abbreviations

腎臓結石治療の世界市場 2024-2028

Global kidney stones therapeutic market 2024-2028

目次

第1章エグゼクティブサマリー

第2章市場情勢

第3章市場規模の評価

第4章市場規模実績

第5章ファイブフォース分析

第6章市場セグメンテーション：エンドユーザー別

第7章市場セグメンテーション：タイプ別

第8章顧客情勢

第9章地域別情勢

第10章促進要因・課題・機会・抑制要因

第11章競合情勢

第12章競合分析

第13章付録

Table of Contents

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Historic Market Size

5 Five Forces Analysis

6 Market Segmentation by End-user

7 Market Segmentation by Type

8 Customer Landscape

9 Geographic Landscape

10 Drivers, Challenges, and Opportunity/Restraints

11 Competitive Landscape

12 Competitive Analysis

13 Appendix

腎臓結石治療の世界市場 2024-2028

Global kidney stones therapeutic market 2024-2028

目次

第1章 エグゼクティブサマリー

第2章 市場情勢

第3章 市場規模の評価

第4章 市場規模実績

第5章 ファイブフォース分析

第6章 市場セグメンテーション：エンドユーザー別

第7章 市場セグメンテーション：タイプ別

第8章 顧客情勢

第9章 地域別情勢

第10章 促進要因・課題・機会・抑制要因

第11章 競合情勢

第12章 競合分析

第13章 付録

Table of Contents

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Historic Market Size

5 Five Forces Analysis

6 Market Segmentation by End-user

7 Market Segmentation by Type

8 Customer Landscape

9 Geographic Landscape

10 Drivers, Challenges, and Opportunity/Restraints

11 Competitive Landscape

12 Competitive Analysis

13 Appendix

第1章エグゼクティブサマリー

第2章市場情勢

第3章市場規模の評価

第4章市場規模実績

第5章ファイブフォース分析

第6章市場セグメンテーション：エンドユーザー別

第7章市場セグメンテーション：タイプ別

第8章顧客情勢

第9章地域別情勢

第10章促進要因・課題・機会・抑制要因

第11章競合情勢

第12章競合分析

第13章付録